Trial intelligence / Profile preview

Doxazosin and Modafinil for Cocaine Dependence

NCT02538744Phase 1Completed

Sponsor
Baylor College of Medicine
Start
Aug 2015
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of doxazosin and modafinil in cocaine dependence (2 arms), sponsored by Baylor College of Medicine. Primary endpoint: Subjective effects (VAS) at 60 minutes. Started Aug 2015; status: completed.

02

Drugs

doxazosinmodafinil
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT02538744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02538744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call